Abstract
The aim of this study was to perform an individual patient-level pooled analysis of randomised trials, comparing intracoronary versus intravenous abciximab bolus use in patients with ST-segment elevation myocardial infarction (STEMI) undergoing primary percutaneous coronary intervention (PCI).
| Originalsprog | Engelsk |
|---|---|
| Tidsskrift | Heart |
| ISSN | 1355-6037 |
| DOI | |
| Status | Udgivet - 24 maj 2012 |
Fingeraftryk
Dyk ned i forskningsemnerne om 'Clinical impact of intracoronary abciximab in patients undergoing primary percutaneous coronary intervention: an individual patient data pooled analysis of randomised studies'. Sammen danner de et unikt fingeraftryk.Citationsformater
- APA
- Standard
- Harvard
- Vancouver
- Author
- BIBTEX
- RIS